Evidence of a substantial decline in prevalence of HIV-1 infection among pregnant women: Data from 1995 to 2003 in Dar es Salaam, Tanzania

Scandinavian Journal of Public Health

Volumn 34, Issue 3, 2006, Pages 272-278

  Urassa, Willy ^a   Mwakagile, Davis ^a   Kaaya, Sylvia ^a   O'brien, Megan ^b   Antelman, Gretchen ^b   Hunter, David ^b   Fawzi, Wafaie ^b   Msamanga, Gernard ^a  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Africa; ANC; decline; HIV infection; seroprevalence

Indexed keywords

ANTIBIOTIC AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NEVIRAPINE; VITAMIN;

AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOASSAY; INFANT; INFORMED CONSENT; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; PREGNANCY DISORDER; PREGNANCY OUTCOME; PRENATAL CARE; PRIORITY JOURNAL; SCREENING TEST; SOCIOECONOMICS; TANZANIA; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGE FACTORS; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV SEROPREVALENCE; HIV-1; HUMANS; INTERVIEWS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TANZANIA;

EID: 33744939738     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1080/14034940500434871     Document Type: Article

References (24)

1. Unaids/Who. AIDS epidemic update December 2004. Joint United Nations Programme on HIV/AIDS (UNAIDS). Geneva: World Health Organisation; 2005.
2. Gunnar H., Shao J., Mhalu F., et al. The AIDS epidemic in Tanzania: Rate of spread of HIV in blood donors and pregnant women in Dar es Salaam. Scand J Infect Dis 1992;24:701-6.
3. Mwakagile D., Swai A., Sandstrom E., et al. High frequency of sexuality transmitted diseases among pregnant women in Dar es Salaam, Tanzania: Need for intervention. East Afr Med J 1996; 73:675-8.
4. Petry K., Kingu H. HIV infection among pregnant women in Lindi, Tanzania, 1989—1993. Intern STD/AIDS 1996;7:265-8.
5. Mbulaiteye S., Mahe C., Whitworth J., et al. Declining HIV-1 incidence and associated prevalence over 10 years in rural population in South-west Uganda: a cohort study. Lancet 2002;360:41-46.
6. Asamoah-Odei E., Calleja J., Boerma J. HIV prevalence and trends in sub-Saharan Africa: No decline and large sub regional differences. Lancet 2004;364:35-40.
7. Tsegaye A., Rinke de Wit T., Mekonnen Y., et al. Decline in prevalence of HIV-1 infection and syphilis among young women attending antenatal care clinics in Addis Ababa, Ethiopia: Results from sentinel surveillance, 1995—2001. J Acquir Immune Defic Syndr 2002;30:359-362.
8. Kwesigabo G., Killewo J., Urassa W., et al. Monitoring of HIV-1 infection prevalence and trends in the general population using pregnant women as a sentinel population: 9 years’ experience from the Kagera region of Tanzania. J Acquir Immune Defic Syndr 2000;23:410-417.
9. Kwesigabo G., Killewo J., Godoy C., et al. Decline in the prevalence of HIV-1 infection in young women in the Kagera region of Tanzania. J Acquir Immune Defic Syndr Human Retrovirol 1998;17:262-8.
10. Kwesigabo G. Trends of HIV infection in the Kagera region of Tanzania 1987—2000. Umea University Medical Dissertations New Series No 710, Umea, Sweden: Umea University; 2001.
11. Lugalla J., Emmelin M., Mutembei A., et al. Social cultural and sexual behavioural determinants of observed decline of HIV infection trends: Lessons from Kagera region, Tanzania. Soc Sci Med 2004;59:185-198.
12. Fawzi W., Msamanga G., Spiegelman D., et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 1998;351:1477-1482.
13. Fawzi W.W., Villamor E., Msamanga G.I., et al. Trial of zinc supplements in relation to pregnancy outcomes, hematologic indicators, and T cell counts among HIV-1-infected women in Tanzania. Am J Clin Nutr 2005;81:161-7.
14. Urassa W., Bredberg-Raden U., Mbena E., et al. Alternative confirmatory strategies in HIV-1 antibody testing. J Acquir Immune Defic Syndr 1992;5:170-6.
15. Urassa W., Matunda S., Bredberg Raden U., et al. Evaluation of the WHO human immunodeficiency virus (HIV) antibody testing strategy for the diagnosis of HIV infection. Clin Diagn Virol 1994;2:1-6.
16. WHO Proposed criteria for interpretation of results from Western Blot for HIV-1, HIV-2, HTLV-1, and HTLV-II. Wkly Epidemiol Rec 1990;39:281-3.
17. Anderson R., Rosenberg H. Age standardization of death rates: Implementation of the year 2000 standard. Natl Vital Stat Rep 1998;47:1-16.
18. Agresti A., Coull B. Approximate is better than “exact” for interval estimation of binomial proportions. Am Sta 1998; 52:119-126.
19. Kigadye R., Klokke A., Nicoll A., et al. Sentinel surveillance for HIV-1 among pregnant women in developing country: 3 years’ experience and comparison with a population serosurvey. AIDS 1993;7:949-955.
20. Kwesigabo G., Killewo J., Sandstrom A. Sentinel surveillance and cross-sectional survey on HIV infection prevalence: A comparative study. East Afr Med J 1996;73:298-302.
21. Zaba B., Boerma J., White R. Monitoring the AIDS epidemic using HIV prevalence among young women attending antenatal clinics: Prospects and problems. AIDS 2000;14: 1633-1645.
22. Kilian A., Gregson S., Ndyanabangi B., et al. Reductions in risk behaviour provide the most consistent explanation for declining HIV-1 prevalence in Uganda. AIDS 1999;13: 391-8.
23. Klepp K., Mdeki S., Leshabari M., et al. AIDS education in Tanzania: Promoting risk reduction among primary school children. Am J Public Health 1997;87:1931-6.
24. Urban M., Chersich M. Acceptability and utilisation of voluntary HIV testing and nevirapine to reduce mother-to-child transmission of HIV-1 integrated into routine clinical care. S Afr Med J 2000;94:362-6.